People · Operator
Named in public records as an officer, director or promoter · active 2012–2018 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Crypt Holdings, Inc. | — | Other | Series A | $11.3M | $93.8M | 2015 |
| BioMarker Strategies LLC | — | Biotechnology | Seed | $7.9M | $23.3M | 2013 |
| RedPath Integrated Pathology, Inc. | — | Biotechnology | Seed | $2.8M | $27.2M | 2012 |
Jack Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jack Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Murphy | 1 | 15 |
| Dennis Smith | 1 | 6 |
| Ken Lerer | 1 | 5 |
| Glenn Miller | 1 | 5 |
| Jason Rubin | 1 | 3 |
| Douglas Clark | 1 | 2 |
| Peter Kleinhenz | 1 | 2 |
| JASON BLUM | 1 | 2 |
| Katarzyna Kusmierz | 1 | 2 |
| Mark Velleca | 1 | 2 |
| Joseph Klein | 1 | 2 |
| Christine Wyskiel | 1 | 1 |
| Jack David | 1 | 1 |
| Mark Myslinski | 1 | 1 |
| Jerry Parrott | 1 | 1 |
| Craig S Heryford | 1 | 1 |
| Karen Marie Olson | 1 | 1 |
| Paul Beresford | 1 | 1 |
| Christina Wyskiel | 1 | 1 |
| Sam Broder | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.